These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18441342)

  • 1. Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets.
    Burgoon LD; Zacharewski TR
    Toxicol Sci; 2008 Aug; 104(2):412-8. PubMed ID: 18441342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice.
    Boverhof DR; Burgoon LD; Tashiro C; Sharratt B; Chittim B; Harkema JR; Mendrick DL; Zacharewski TR
    Toxicol Sci; 2006 Dec; 94(2):398-416. PubMed ID: 16960034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
    Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
    PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicogenomic analysis of gender, chemical, and dose effects in livers of TCDD- or aroclor 1254-exposed rats using a multifactor linear model.
    Silkworth JB; Carlson EA; McCulloch C; Illouz K; Goodwin S; Sutter TR
    Toxicol Sci; 2008 Apr; 102(2):291-309. PubMed ID: 18178546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative temporal toxicogenomic analysis of TCDD- and TCDF-mediated hepatic effects in immature female C57BL/6 mice.
    N'Jai A; Boverhof DR; Dere E; Burgoon LD; Tan YS; Rowlands JC; Budinsky RA; Stebbins KE; Zacharewski TR
    Toxicol Sci; 2008 Jun; 103(2):285-97. PubMed ID: 18343893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicogenomic examination of the hepatic effects of PCB126 and TCDD in immature, ovariectomized C57BL/6 mice.
    Kopec AK; Boverhof DR; Burgoon LD; Ibrahim-Aibo D; Harkema JR; Tashiro C; Chittim B; Zacharewski TR
    Toxicol Sci; 2008 Mar; 102(1):61-75. PubMed ID: 18042819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity.
    Boverhof DR; Burgoon LD; Tashiro C; Chittim B; Harkema JR; Jump DB; Zacharewski TR
    Toxicol Sci; 2005 Jun; 85(2):1048-63. PubMed ID: 15800033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene batteries and synexpression groups applied in a multivariate statistical approach to dose-response analysis of toxicogenomic data.
    Parfett C; Williams A; Zheng JL; Zhou G
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):63-74. PubMed ID: 23831126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of biomonitoring equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: a screening tool for interpretation of biomonitoring data in a risk assessment context.
    Aylward LL; Lakind JS; Hays SM
    J Toxicol Environ Health A; 2008; 71(22):1499-508. PubMed ID: 18836925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces organ- specific differential gene expression in male Japanese medaka (Oryzias latipes).
    Volz DC; Bencic DC; Hinton DE; Law JM; Kullman SW
    Toxicol Sci; 2005 May; 85(1):572-84. PubMed ID: 15703262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
    Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
    Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scoring multiple toxicological endpoints using a toxicogenomic database.
    Kiyosawa N; Ando Y; Watanabe K; Niino N; Manabe S; Yamoto T
    Toxicol Lett; 2009 Jul; 188(2):91-7. PubMed ID: 19446240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
    Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMDExpress Data Viewer - a visualization tool to analyze BMDExpress datasets.
    Kuo B; Francina Webster A; Thomas RS; Yauk CL
    J Appl Toxicol; 2016 Aug; 36(8):1048-59. PubMed ID: 26671443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes.
    Thackaberry EA; Jiang Z; Johnson CD; Ramos KS; Walker MK
    Toxicol Sci; 2005 Nov; 88(1):231-41. PubMed ID: 16120747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.
    Thomas RS; Clewell HJ; Allen BC; Wesselkamper SC; Wang NC; Lambert JC; Hess-Wilson JK; Zhao QJ; Andersen ME
    Toxicol Sci; 2011 Mar; 120(1):194-205. PubMed ID: 21097997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Range of Plausible Noncancer Toxicity Values for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Based on Effects on Sperm Count: Application of Systematic Review Methods and Quantitative Integration of Dose Response Using Meta-Regression.
    Wikoff DS; Urban JD; Ring C; Britt J; Fitch S; Budinsky R; Haws LC
    Toxicol Sci; 2021 Jan; 179(2):162-182. PubMed ID: 33306106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmark dose modeling of transcriptional data: a systematic approach to identify best practices for study designs used in radiation research.
    Stainforth R; Vuong N; Adam N; Kuo B; Wilkins RC; Yauk C; Beheshti A; Chauhan V
    Int J Radiat Biol; 2022; 98(12):1832-1844. PubMed ID: 35939275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment.
    Boobis A; Budinsky R; Collie S; Crofton K; Embry M; Felter S; Hertzberg R; Kopp D; Mihlan G; Mumtaz M; Price P; Solomon K; Teuschler L; Yang R; Zaleski R
    Crit Rev Toxicol; 2011 May; 41(5):369-83. PubMed ID: 21309635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.